1. The HEALing (Helping to End Addiction Long-term
- Author
-
Leyla Stambaugh, Emmanuel A. Oga, Debbie M. Cheng, Drew Speer, Terry T.-K. Huang, R. Craig Lefebvre, Katherine L. Thompson, Richard Saitz, Dana Bernson, Katherine R. Marks, Michael W. Konstan, Timothy R. Huerta, Marc R. Larochelle, Jennifer Miles, Nabila El-Bassel, Greg Young, Jag Chhatwal, Jeffrey H. Samet, Bridget Freisthler, Sarah Mann, Daniel J. Feaster, Daniel M. Walker, Michael S. Lyons, Joshua A. Barocas, Frances R. Levin, April M. Young, Danelle Stevens-Watkins, Darcy A. Freedman, Sharon L. Walsh, Eric E. Seiber, Hilary L. Surratt, Bruce D. Rapkin, Andrea Czajkowski, Philip M. Westgate, Sandra Rodriguez, Theresa Winhusen, Damara Gutnick, Benjamin P. Linas, Denis Nash, Pamela J. Salsberry, Michelle R. Lofwall, Joshua L. Bush, Jeffery C. Talbert, Tara McCrimmon, Rebecca D. Jackson, David W. Lounsbury, Kim Toussant, Maneesha Aggarwal, Amy Button, Nicky Lewis, Nathan A. Vandergrift, Hannah K. Knudsen, Nasim S. Sabounchi, Gary A. Zarkin, Dawn Goddard-Eckrich, Cortney C. Miller, Kathryn E. McCollister, Tracy Plouck, Scott T. Walters, Soledad Fernandez, Aimee N.C. Campbell, Heather M. Bush, Edward V. Nunes, Svetla Slavova, LaShawn Glasgow, Bruce R. Schackman, Charles Edward Knott, James L. David, Lisa Rosen-Metsch, Thomas Clarke, Donald W. Helme, Erika L. Crable, Ann Scheck McAlearney, Timothy Hunt, Elwin Wu, Michael D. Slater, Redonna K. Chandler, Arnie Aldridge, Kevin Paul Conway, Caroline Savitsky, Donna Beers, Mari-Lynn Drainoni, Rachel Bowers-Sword, Laura C. Fanucchi, Carrie B. Oser, Robin Kerner, Elisabeth Dowling Root, Carolina Barbosa, Katherine M. Keyes, Carly Bridden, Patricia R. Freeman, Jennifer L. Brown, Michael D. Stein, Alexander Y. Walley, Jennifer Villani, Linda Sprague Martinez, Trevor Baker, Ayaz Hyder, Michele Staton, Louisa Gilbert, Magdalena Cerdá, Kristin Harlow, and Tracy A. Battaglia
- Subjects
medicine.medical_specialty ,Evidence-based practice ,medications for opioid use disorder (MOUD) ,Opioid Use Disorder (OUD) ,media_common.quotation_subject ,New York ,community engagement ,Toxicology ,Article ,law.invention ,Primary outcome ,Clinical Trial Protocols as Topic ,HEALing Communities Study ,Randomized controlled trial ,law ,Medicine ,Humans ,Pharmacology (medical) ,Cluster randomised controlled trial ,Helping to End Addiction Long-term ,media_common ,Ohio ,Randomized Controlled Trials as Topic ,Pharmacology ,Community level ,naloxone ,Community engagement ,business.industry ,Addiction ,Opioid overdose ,medicine.disease ,Opioid-Related Disorders ,Behavior, Addictive ,Psychiatry and Mental health ,Opiate Overdose ,Massachusetts ,Family medicine ,Evidence-Based Practice ,opioid prescribing ,overdose ,Drug Overdose ,business - Abstract
Highlights • HEALing Communities Study is a parallel-group cluster randomized controlled trial. • Communities That HEAL intervention’s goal is to reduce opioid overdose deaths. • Structured consensus decision-making strategy guided study measure development. • More than 80 study measure specifications and a common data model were developed. • The study will provide methodology and longitudinal community data for research., Background Opioid overdose deaths remain high in the U.S. Despite having effective interventions to prevent overdose deaths, there are numerous barriers that impede their adoption. The primary aim of the HEALing Communities Study (HCS) is to determine the impact of an intervention consisting of community-engaged, data-driven selection, and implementation of an integrated set of evidence-based practices (EBPs) on reducing opioid overdose deaths. Methods The HCS is a four year multi-site, parallel-group, cluster randomized wait-list controlled trial. Communities (n = 67) in Kentucky, Massachusetts, New York and Ohio are randomized to active intervention (Wave 1), which starts the intervention in Year 1 or the wait-list control (Wave 2), which starts the intervention in Year 3. The HCS will test a conceptually driven framework to assist communities in selecting and adopting EBPs with three components: 1) A community engagement strategy with local coalitions to guide and implement the intervention; 2) A compendium of EBPs coupled with technical assistance; and 3) A series of communication campaigns to increase awareness and demand for EBPs and reduce stigma. An implementation science framework guides the intervention and allows for examination of the multilevel contexts that promote or impede adoption and expansion of EBPs. The primary outcome, number of opioid overdose deaths, will be compared between Wave 1 and Wave 2 communities during Year 2 of the intervention for Wave 1. Numerous secondary outcomes will be examined. Discussion The HCS is the largest community-based implementation study in the field of addiction with an ambitious goal of significantly reducing fatal opioid overdoses.
- Published
- 2020